MEDINCELL has a total of 84 patent applications. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and basic materials chemistry are DEXCEL PHARMA TECHNOLOGIES LTD, NANOCARRIER KABUSHIKI KAISHA and JIANGSU FEIMA PHARMACEUTICAL IND CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | EPO (European Patent Office) | 8 | |
#4 | Canada | 5 | |
#5 | United Kingdom | 5 | |
#6 | Australia | 4 | |
#7 | Argentina | 3 | |
#8 | China | 3 | |
#9 | Republic of Korea | 3 | |
#10 | Singapore | 3 | |
#11 | Brazil | 2 | |
#12 | Chile | 2 | |
#13 | Colombia | 2 | |
#14 | Costa Rica | 2 | |
#15 | Cuba | 2 | |
#16 | EAPO (Eurasian Patent Organization) | 2 | |
#17 | Israel | 2 | |
#18 | Morocco | 2 | |
#19 | Mexico | 2 | |
#20 | Tunisia | 2 | |
#21 | South Africa | 2 | |
#22 | Hong Kong | 1 | |
#23 | Hungary | 1 | |
#24 | India | 1 | |
#25 | Japan | 1 | |
#26 | Montenegro | 1 | |
#27 | Malaysia | 1 | |
#28 | New Zealand | 1 | |
#29 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Basic materials chemistry | |
#4 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Gaudriault Georges | 60 |
#2 | Roberge Christophe | 35 |
#3 | Serindoux Juliette | 14 |
#4 | Petit Audrey | 13 |
#5 | Abbassi Myriam | 13 |
#6 | Pebrel Lea | 13 |
#7 | Rech Anthony | 12 |
#8 | Cros Jean-Manuel | 11 |
#9 | Grizot Sylvestre | 8 |
#10 | López-Noriega Adolfo | 7 |
Publication | Filing date | Title |
---|---|---|
GB202010340D0 | Pharmaceutical composition | |
GB201905093D0 | Device | |
GB201905095D0 | Refill apparatus | |
GB201900258D0 | Pharmaceutical composition | |
AU2018304881A1 | Pharmaceutical composition | |
KR20180091016A | A method for micellising and / or targeting an active ingredient that is pharmaceutically active in synovial tissue | |
MX2014015902A | Biodegradable drug delivery for hydrophobic compositions. | |
MY165655A | Biodegradable drug delivery compositions |